Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

For many people with migraine, it can be difficult to find a treatment that is effective and reliable, and information on how medications compare to one another is lacking.

EAN 2024: anti-CGRPs more effective than onabotulinumtoxinA in chronic migraine prevention in real world

On 30 June 2024, at the tenth Congress of the European Academy of Neurology (EAN) 2024, during an e-presentation session on the topic of ‘Headaches’,

July 2, 2024

Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC

Adding tislelizumab to neoadjuvant chemotherapy followed by adjuvant use of the investigational PD-1 inhibitor improved event-free survival (EFS) in resectable non-small cell lung cancer (NSCLC),

February 17, 2024

WakeMed to Deploy Regard’s AI Clinical Automation Platform Across Enterprise

What You Should Know: – WakeMed Health & Hospitals and Regard today announced a 3-year enterprise agreement to deploy Regard’s AI clinical automation tool to

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.